Category:natural substances and extractives
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Physical Properties:
Assay: | 95.00 to 100.00
|
Food Chemicals Codex Listed: | No |
Specific Gravity: | 1.02000 @ 25.00 °C.
|
Refractive Index: | 1.52600 to 1.53000 @ 20.00 °C.
|
Melting Point: | 30.50 °C. @ 760.00 mm Hg
|
Boiling Point: | 325.00 °C. @ 760.00 mm Hg
|
Flash Point: | > 230.00 °F. TCC ( > 110.00 °C. )
|
logP (o/w): | 3.210 (est) |
Soluble in: |
| water, 3040 mg/L @ 22 °C (exp) | | water, 1374 mg/L @ 25 °C (est) |
Organoleptic Properties:
Odor and/or flavor descriptions from others (if found). |
Cosmetic Information:
Suppliers:
Safety Information:
Preferred SDS: View |
|
Hazards identification |
|
Classification of the substance or mixture |
GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
None found. |
GHS Label elements, including precautionary statements |
|
Pictogram | |
|
Hazard statement(s) |
None found. |
Precautionary statement(s) |
None found. |
Oral/Parenteral Toxicity: |
intravenous-dog LD50 15 mg/kg Veterinary and Human Toxicology. Vol. 41, Pg. 33, 1999.
intramuscular-frog LDLo 1665 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1398, 1935.
intraperitoneal-guinea pig LDLo 23 mg/kg Journal of Agricultural Research Vol. 32, Pg. 51, 1926.
intravenous-guinea pig LDLo 27 mg/kg LUNGS, THORAX, OR RESPIRATION: DYSPNEA
BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY)
BEHAVIORAL: TREMOR Planta Medica. Vol. 50, Pg. 420, 1984.
intraperitoneal-mouse LD50 36 mg/kg BEHAVIORAL: TREMOR
BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY)
LUNGS, THORAX, OR RESPIRATION: DYSPNEA Planta Medica. Vol. 50, Pg. 420, 1984.
oral-mouse LD50 220 mg/kg LUNGS, THORAX, OR RESPIRATION: DYSPNEA
BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY)
BEHAVIORAL: TREMOR Planta Medica. Vol. 50, Pg. 420, 1984.
intravenous-rabbit LDLo 30 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1398, 1935.
intraperitoneal-rat LD50 42 mg/kg Compilation of LD50 Values of New Drugs.
oral-rat LD50 960 mg/kg Archives Internationales de Pharmacodynamie et de Therapie. Vol. 210, Pg. 27, 1974.
|
Dermal Toxicity: |
subcutaneous-frog LDLo 3330 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1398, 1935.
subcutaneous-mouse LD50 105 mg/kg Pharmacology and Toxicology. English translation of FATOAO. Vol. 21, Pg. 468, 1958.
subcutaneous-rabbit LDLo 100 mg/kg "Structure et Activite Pharmacodyanmique des Medicaments du Systeme Nerveux Vegetatif," Bovet, D., and F. Bovet-Nitti, New York, S. Karger, 1948Vol. -, Pg. 589, 1948.
|
Inhalation Toxicity: |
Not determined
|
Safety in Use Information:
Category: | natural substances and extractives |
Recommendation for (-)-sparteine usage levels up to: | | not for fragrance use.
|
|
Recommendation for (-)-sparteine flavor usage levels up to: |
| not for flavor use.
|
Safety References:
References:
Other Information:
Potential Blenders and core components note
Potential Uses:
Occurrence (nature, food, other): note
Synonyms:
| esparteina | | genisteine alkaloid | | lupinidine | 7,14- | methano-2H,6H-dipyrido(1,2-a:1',2'-e)(1,5)diazocine, dodecahydro- | 7,14- | methano-2H,6H-dipyrido(1,2-a:1',2'-e)(1,5)diazocine, dodecahydro-, (7S-(7alpha,7aalpha,14alpha,14abeta))- | 6-beta,7-alpha,9-alpha,11-alpha- | pachycarpine | | sparteina | L- | sparteine | | sparteinum |
Articles:
|